Tuesday, January 15, 2008

CNBC burning its viewers?

*not a recommendation to buy or sell a security, for education and awareness only!*

st0ckman's analysis of cnbc's coverage(promotion?) of the defense sector.

from a dow theory point of view the defense sector (DFI) looks like it is going into distribution. did the cfr pick a democrat for president in 09? This can hurt the military industrial sector.

ron paul is a huge republican threat to the military industrial complex and is extremely anti federal government. he also wants to end the wars immediately.
is the good doctor already crushing defense?

is the smart money cashing out? worse yet, is cnbc being used to dump defense stocks?

do they know something most do not?

full analysis on my youtube video.

-question everything - st0ckman

Video - CNBC.com

Video - CNBC.com

Why Free Energy Is Not Available Today

Ron Paul on Larry King 1-3-08 (UNAIRED)

-un aired on tv

Video - CNBC.com

Video - CNBC.com


NYSE Morning Preview
Bob Pisani reports on the trading day from the NYSE

U.S. futures lower after Citi, Merril injections, retail report - MarketWatch

U.S. futures lower after Citi, Merril injections, retail report - MarketWatch

Financials were in focus, as Citigroup (C:
Sponsored by:
, , )
said it would cut its dividend by 40%, and get a $12.5 billion capital injection from investors including Singapore and Kuwait after reporting a $9.8 billion quarterly loss.
Merrill Lynch (MER:
Sponsored by:
, , )
meanwhile announced it was getting a $6.6 billion injection, notably from sovereign wealth funds of Kuwait and Korea as well as Japan's Mizuho Corporate Bank (MFG:
Sponsored by:
, , )
Merrill Lynch lost 1.9% in pre-open deals, and Citi slipped 1.6%.
Intel (INTC:
Sponsored by:
, , )
after the close will report its quarterly performance.
Genentech (DNA:
Sponsored by:
, , )
fell 2.3% in pre-open trade after the biotech said late Monday that its fourth-quarter profit rose 6%.
AstraZeneca (AZN:
Sponsored by:
, , )
said it would test its Crestor drug against Pfizer's (PFE:
Nokia (NOK:
The Nikkei 225 fell below the 14,000 level in Tokyo for the first time since November 2005. Losses for drugmakers as well as retailers pulled the FTSE 100 down 1.6% in London. End of Story

premarket 24/7 Wall St.

24/7 Wall St.

Pre-Market Stock Movers (January 15, 2008) (EDU, COIN, CWTR, DNDN, DNA, WSM, FRX, LCBM, NWY, STT, PVH, TMA)

Below is a snapshot of the key pre-market news that we are focusing on for early pre-market trading this Tuesday:

  • Apple (AAPL) has its Macworld today.
  • CECO Environmental (CECE) announced 14 new orders received totaling ~ $7.3 million.
  • Charles & Colvard (CTHR) lowered guidance and announced a strategic review.
  • Citigroup (C) was trading up but then went negative in early trading: -$1.99 EPS vs -$1.00 estimate, huge charges of $18.1 Billion, 4,200 layoffs included, review divestitures, cut $0.54 dividend down to $0.32.
  • Coldwater Creek (CWTR) lowered guidance, again, again. Shares down 15% to new low.
  • Converted Organics (COIN) announced its has secured a Rhode Island site for second organic fertilizer facility; stock down 6% pre-market.
  • Dendreon (DNDN) received a European patent covering Provenge and its ACI platform technology; shares up 5% pre-market after solid gains yesterday.
  • First American Financial (FAF) sees revenues of $1.9 Billion as expected but sees charges and writedowns.
  • Forest Labs (FRX) $0.96 EPS vs $0.75 estimate; Revenues $998.2 million versus $946+ million estimate. Raised 2008 guidance.
  • Genentech (DNA) trading down 2% pre-market after beating earnings but missing estimates on its top 4 drugs; sees 2008 EPS $3.30-3.45 vs. $3.37 estimate.
  • Kellwood (KWD) $21.00 tender from Sun Capital affiliate Cardinal Integrated commences.
  • Kosan (KOSN) initiated Phase II trials of alvespimycin, their second-generation inhibitor in patients with HER2-positive metastatic breast cancer.
  • Lifecore Biomedical (LCBM) trading up 29% after it agreed to be acquired by Warburg Pincus for $17.00 per share in cash.
  • Merrill Lynch (MER) confirmed that it has agreed to issue $6.6 Billion in preferred stock.
  • New Oriental Education & Technology (EDU) $0.10 EPS vs. $0.08 estimate.
  • New York & Co. (NWY) lowered guidance.
  • OSI Systems (OSIS) received a follow-on order from EDO Corporation for roughly $5.8 million.
  • Phillips-Van Heusen (PVH) guidance for Q4 EPS at least $0.53, previous guidance was $0.51 to 0.53 and $0.53 First Call; also reaffirmed FY08 EPS of $3.55 to 3.65 vs. $3.55 estimate.
  • State Street (STT) issued earnings and is indicated down 1% to 3% on thin volume after noting it sees 2008 at lower end of target.
  • Thornburg Mortgage (TMA) raised roughly $212 million in equity and convertible preferred securities sales; stock down 1% pre-market.
  • William Sonoma (WSM) lowered guidance; stock down 14% pre-market.

NYSE Arca Morning Update

NYSE Arca Morning Update

Stocks trading on NYSE Arca at a price more than 15% away from the previous trade day's consolidated close price. (As of 08:30:00 ET)

Monday's Close Current Price Pct Chng Current NYSE Arca Vol



( 42%)















( 19%)







lcbm - cash deal look for flat line chart
mana - cash deal look for flat line chart
hibb - poor earnings
kwd - cash deal look for flat line chart


Company Name

Last Sale (Pre-Market) % Change


Lifecore Biomedical, Inc.
$12.84 $16.75 30.45% 140,880

Pozen, Inc.
$11.86 $13.50 13.83% 7,100

SumTotal Systems, Inc.
$3.98 $4.50 13.07% 27,200

DepoMed, Inc.
$3.31 $3.72 12.39% 15,599

no interesting gaps today

Subscribe to "The $t0ckman" via email

Enter your email address:

Delivered by FeedBurner